Skip to main content
Toggle navigation
Search
Home
Full Schedule
Home
Full Schedule
All Days
Wed, Nov 1
Thu, Nov 2
Fri, Nov 3
On-Demand
Full Schedule
Type here to filter the list
Friday, November 3, 2023
8:00 AM – 8:15 AM
ET
Welcome and Introduction
8:00 AM – 8:15 AM
ET
Welcome and Introduction
8:15 AM – 8:50 AM
ET
Session 15: Special Topics in HR+ Breast Cancer
8:15 AM – 8:50 AM
ET
Session 15: Special Topics in HR+ Breast Cancer
Presenter:
Kevin Kalinsky, MD, MS
– Winship Cancer Institute at Emory University
8:50 AM – 9:00 AM
ET
Live Q&A
8:50 AM – 9:00 AM
ET
Live Q&A
Moderator:
Erika P. Hamilton, MD
– Sarah Cannon Research Institute (SCRI)
Presenter:
Kevin Kalinsky, MD, MS
– Winship Cancer Institute at Emory University
9:00 AM – 9:15 AM
ET
Break
9:00 AM – 9:15 AM
ET
Break
9:15 AM – 10:00 AM
ET
Session 16: ER-Positive Targeted Therapy: PI3, AKT, mTOR, etc
9:15 AM – 10:00 AM
ET
Session 16: ER-Positive Targeted Therapy: PI3, AKT, mTOR, etc
Presenter:
Joyce O'Shaughnessy, MD
– Baylor Charles A. Sammons Cancer Center/ Baylor University Medical Center/ Texas Oncology
10:00 AM – 10:15 AM
ET
Break
10:00 AM – 10:15 AM
ET
Break
10:15 AM – 11:15 AM
ET
Non-CME Innovation Theater
10:15 AM – 11:15 AM
ET
Non-CME Innovation Theater
11:15 AM – 11:30 AM
ET
Break
11:15 AM – 11:30 AM
ET
Break
11:30 AM – 12:05 PM
ET
Session 17: HER2-Positive Metastatic Breast Cancer: Where are We Headed?
11:30 AM – 12:05 PM
ET
Session 17: HER2-Positive Metastatic Breast Cancer: Where are We Headed?
Presenter:
Sara Hurvitz, MD
– University of California, Los Angeles
11:30 AM – 12:15 PM
ET
Session 17: HER2-Positive Metastatic Breast Cancer: Where are We Headed?
12:05 PM – 12:15 PM
ET
Live Q&A
Moderator:
Erika P. Hamilton, MD
– Sarah Cannon Research Institute (SCRI)
Presenter:
Sara Hurvitz, MD
– University of California, Los Angeles
12:15 PM – 12:30 PM
ET
Break
12:15 PM – 12:30 PM
ET
Break
12:30 PM – 1:05 PM
ET
Session 18: Immunotherapy for Breast Cancer
12:30 PM – 1:05 PM
ET
Session 18: Immunotherapy for Breast Cancer
Presenter:
Javier Cortes, MD, PhD
– International Breast Cancer Center , IBCC
1:05 PM – 1:15 PM
ET
Live Q&A
1:05 PM – 1:15 PM
ET
Live Q&A
Moderator:
Erika P. Hamilton, MD
– Sarah Cannon Research Institute (SCRI)
Presenter:
Javier Cortes, MD, PhD
– International Breast Cancer Center , IBCC
1:15 PM – 1:30 PM
ET
Break
1:15 PM – 1:30 PM
ET
Break
1:30 PM – 2:05 PM
ET
Session 19: ADCs: A New Technology
1:30 PM – 2:05 PM
ET
Session 19: ADCs: A New Technology
Presenter:
Giuseppe Curigliano, Professor MD PhD
– European Insitute of Oncology, IRCCS and University of Milano
2:05 PM – 2:15 PM
ET
Live Q&A
2:05 PM – 2:15 PM
ET
Live Q&A
Moderator:
Erika P. Hamilton, MD
– Sarah Cannon Research Institute (SCRI)
Presenter:
Giuseppe Curigliano, Professor MD PhD
– European Insitute of Oncology, IRCCS and University of Milano
2:15 PM – 2:30 PM
ET
Break
2:15 PM – 2:30 PM
ET
Break
2:30 PM – 3:15 PM
ET
Session 20: Novel Endocrine Backbones
2:30 PM – 3:15 PM
ET
Session 20: Novel Endocrine Backbones
Presenter:
Erika P. Hamilton, MD
– Sarah Cannon Research Institute (SCRI)
3:15 PM – 3:30 PM
ET
Break
3:15 PM – 3:30 PM
ET
Break
3:30 PM – 4:05 PM
ET
Session 21: HER2-Low Breast Cancer: Limits of Testing and Where To Go From Here
3:30 PM – 4:05 PM
ET
Session 21: HER2-Low Breast Cancer: Limits of Testing and Where To Go From Here
Presenter:
Paolo Tarantino, MD
– Dana-Farber Cancer Institute, Harvard Medical School
4:05 PM – 4:15 PM
ET
Live Q&A
4:05 PM – 4:15 PM
ET
Live Q&A
Moderator:
Erika P. Hamilton, MD
– Sarah Cannon Research Institute (SCRI)
Presenter:
Paolo Tarantino, MD
– Dana-Farber Cancer Institute, Harvard Medical School
